简体中文
|
繁體中文
|
English
Business Wire Global sites
Business Wire Global
UK/Ireland
Deutschland
France
Italy
Japan
Home
News
Events
Media Services
About Us
Contact Us
Health and Pharmaceutical Press Releases
2017-11-02 13:55
PMC Group International Announces Acquisition of Pharma Company in India
2017-10-31 15:34
GRAMINEX L.L.C. expands its partnership with IDIPharma after clinical study publication.
2017-10-31 09:54
Boehringer Ingelheim expands collaboration with Sarah Cannon Research Institute to investigate novel immuno-oncology combination therapy
2017-10-30 10:51
Efficacy and Safety Results from Second Phase III Trial (RADIANCE™ Part B) of Oral Ozanimod Versus an Active Comparator in Relapsing Multiple Sclerosis Presented at MSParis2017 – 7th Joint ECTRIMS – ACTRIMS Meeting
2017-10-30 10:43
Efficacy and Safety Results from First Phase III Trial of Oral Ozanimod (SUNBEAM™) Versus an Active Comparator in Relapsing Multiple Sclerosis Presented at MSParis2017 – 7th Joint ECTRIMS – ACTRIMS Meeting
2017-10-26 09:44
Janssen’s New Darunavir-Based Single Tablet Regimen SYMTUZA® Shows Positive Outcome in Treatment of Antiretroviral-Naïve HIV Patients
2017-10-25 14:02
ABEC 4,000 Liter Single-Use Bioreactor to Expand Emergent BioSolutions Manufacturing Capability
2017-10-24 09:22
Hallstar’s New Photostabilizer, AvoBrite®, Solves Customers’ Regulatory Challenges While Delivering Outstanding Photoprotection
2017-10-20 09:34
Phase III Efficacy and Safety Data for Oral Ozanimod in Relapsing Multiple Sclerosis to Be Presented at MSParis2017 – 7th Joint ECTRIMS – ACTRIMS Meeting
2017-10-17 15:40
Takeda Presents Updated Results from Pivotal Phase 2 ALTA Trial of ALUNBRIGTM (brigatinib) in ALK-Positive Non-Small Cell Lung Cancer
2017-10-17 09:50
AstraZeneca and Chi-Med’s Savolitinib Shows Encouraging Clinical Activity in 2nd-Line EGFR Mutation-positive Lung Cancer with MET-amplification
2017-10-17 09:48
Results from Phase 2 Studies of Oral Ozanimod in Crohn’s Disease and Ulcerative Colitis to Be Presented at World Congress of Gastroenterology at ACG2017
2017-10-16 10:02
Herbalife Nutrition Survey Reveals APAC Consumers Concerned About Aging-Related Health Issues but Underestimate the Importance of Nutrition in Healthy Aging
2017-10-16 09:58
FASLODEX (FULVESTRANT) RECEIVES POSITIVE CHMP OPINION FOR THE TREATMENT OF HORMONE RECEPTOR-POSITIVE ADVANCED BREAST CANCER IN COMBINATION WITH PALBOCICLIB1
2017-10-13 10:14
VitalityLife Provides Innovative Health Services and More Accurate Underwriting with Munich Re’s ALLFINANZ Underwriting Software
2017-10-12 12:48
Harbour BioMed Announces Multi-Year Transgenic Platform Licensing Agreement with Innovent Biologics, Inc. for Fully Human Monoclonal Antibody Drug Discovery
2017-10-11 11:25
düber Technologies Inc. Announces SAFT-based ICO to Transform the Cannabis Industry
2017-10-11 10:15
Ferring Strengthens Growth Hormone Franchise Zomacton® Through Acquisition of ZomaJet™ Needle-Free Injector Device
2017-10-11 09:45
Drink GlycoCafé, The Most Complete Cup of Coffee In the World
2017-10-10 21:04
SAISON INFORMATION SYSTEMS: Data Integration Streamlines Japanese City's Healthcare
<< First
< Previous
196
197
198
199
200
201
202
203
204
205
Next >
Last >>
36287
36272
36265
36256
36255
36239
36232
36219
36194
36172
36167
36166
36156
36155
36143
36131
36116
36111
36109
36106
Business Wire Weibo
Press Releases
Corporate Social Responsibility
Manufacturing
Chemical
Health and Pharmaceutical
Property
Travel
Automotive
Life and Entertainment
Energy and Environmental
Retail
Transportation
Business and E-commerce
Communications and Media
Metals and Mining
Finance
Technology
Sports
Education
Art and Culture
Legal
Latest Releases
2026-05-09 17:08
Datavault AI Announces Board of Directors Has Requested Management’s Complete Plan for Dividend Spin-Out of Acoustic Sciences Division into Stand-Alone Public Company
2026-05-09 16:53
UAE Commits $49bn to Local Manufacturers
2026-05-09 16:51
Twilio’s Next Generation Platform: An Infrastructure Layer for Every Conversation in the Agentic Era
2026-05-09 16:48
Beneq Appoints Dr. Jason Harrison as Chief Executive Officer
2026-05-09 16:44
Asset Value Investors (AVI) Urges Rohto Pharmaceutical to Focus on Core Businesses and Engage More Constructively with Shareholders